Cytokinetics (CYTK) Competitor Comparison
We are evaluating the key criteria listed to compare Cytokinetics (CYTK) against its competitors in the Biotechnology industry.
Market Capitalization
24 / 368Gross Profits
253 / 278Total Revenue
189 / 300EBITDA
322 / 337Free Cashflow
336 / 352Quick Ratio
133 / 357Earnings per Share
307 / 359Dividend yield
0 / 6Total Cash
57 / 358Performance 3 years
80 / 368Performance 5 years
20 / 368Performance 10 years
9 / 368Linearity 3 years
31 / 368Linearity 5 years
333 / 368Linearity 10 years
364 / 368Total Rank
308 / 368Dividend Rank
104 / 368Valuation Rank
287 / 368Piotroski Rank
273 / 368Muliplier Rank
326 / 368EBITDA - CYTK ranking 322 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.